Those in the top quarter of Total Antioxidant Capacity (TAC) in their diet halve their risk, in a study of 2,716 people over age 60 (1)
Drugs such as liraglutide, semaglutide, dulaglutide, and the dual GLP-1/GIP receptor agonist tirzepatide demonstrate robust efficacy for weight reduction and glycemic optimization
Current research is exploring the use of BPC-157 in experimental settings for conditions such as: Musculoskeletal injuries (tendons, ligaments, muscles) Gut lining repair and inflammatory bowel conditions Post-operative recovery Inflammatory-related disorders It is important to note that evidence in humans is still emerging, and use should always be discussed with a qualified clinician who can evaluate safety, dosage, and appropriateness on a case-by-case basis
It is not obvious that the methionine cycle would need to be supported by a biochemical like glutathione, whose formation is considered to be dependent on the function of the methionine cycle
